Intellia continues rally after big equity raise upsize, boosts peers
30/06/2021 16:57
** Intellia Therapeutics NTLA.O shares up 23.3% to
$186.90, hits fresh record high $202.73 on Weds, after co raises
50% more equity than planned
** NTLA late Tues announced ~4.1 mln shares at $145 for
gross raise of ~$600 mln with Goldman Sachs, Jefferies, SVB
Leerink and Barclays as jt bookrunners urn:newsml:reuters.com:*:nGNX4YFkXC
** Deal size hiked from $400 mln targeted upon launch
** Stock now up ~110% since co and partner Regeneron
REGN.O early Mon posted positive interim data from ongoing
early-stage trial for its genome editing candidate urn:newsml:reuters.com:*:nL3N2OA2N8
** NTLA news spills over to other gene editors: Beam
Therapeutics Inc BEAM.O , Crispr Therapeutics AG CRSP.O and
Editas Medicine Inc EDIT.O up between 9%-20% on Weds
** Verve Therapeutics VERV.O and Graphite Bio GRPH.O ,
which both went public recently, up 20% and 16%, respectively
urn:newsml:reuters.com:*:nL2N2OA1AA on the session
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 1-332-219-1430))